Clinical Trials Browser

OTHER × Breast Neoplasms × imetelstat × Clear all

NCT01265927 2015-10-27

A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer

Phase 1 Completed

Breast Neoplasms